Message #16 From:
Stock News Bot Date: December 21, 2006 05:00:00 AM
CAPS News Caprius, Inc. Announces 46% 2006 Revenue Growth and New Business Developments
HACKENSACK, N.J.--(BUSINESS WIRE)--Caprius, Inc. (OTCBB: CAPS) announced revenue for the year ended
September 30, 2006 totaled $1,235,469 compared to $848,802 last year, an
increase of approximately 46%. Revenue for the fourth quarter ended
September 30, 2006 was $401,967, a 25% sequential increase compared to
the third quarter ended June 30, 2006. This increase continues the
Company’s sequential quarterly revenue growth
of 13% and 18% for the second and third quarters of 2006, respectively.
Dwight Morgan, President & CEO of Caprius, commented, “Fiscal
2006 was a pivotal year for Caprius. During the year we transitioned to
a sales focused organization committed to realizing the market
opportunity for our SteriMed Systems. This was evidenced by the strong
fourth quarter.”
Commenting on Fiscal 2007, Mr. Morgan continued, “As
we head into Fiscal 2007, we have before us many opportunities to
significantly expand the market penetration of our SteriMed Systems. We
are presently in the process of deploying our SteriMed Systems to
several dialysis clients, including two that are the leaders in the
field both domestically and overseas. One has already received initial
shipments and we are on track to ship units to the second dialysis group
in early 2007. These customers, with multiple locations both here and
abroad, represent a huge opportunity for us in this critical market
niche."
In Fiscal 2006, we shipped two SteriMed Juniors to the United States
Department of Defense for use by the U.S. Navy. The program for the Navy
represents a significant opportunity for us in that the Navy is actively
seeking a ‘total fleet solution’
to medical waste management problems. The Navy had identified 21
potential alternative technology solution providers for medical waste
treatment. Our SteriMed Junior was identified as a solution that
achieved the Navy’s cost, ship impact, and
performance metrics. The first unit was for laboratory test and
evaluation as part of the U.S. Navy’s
Shipboard Medical Waste Management Program and the second unit is
scheduled for shipboard evaluation in early 2007.
These results are as reported in our recently filed Form 10-KSB.
About Caprius
Caprius, Inc. is a manufacturer of proprietary equipment for the on-site
disinfection and disposal of infectious medical waste through its
subsidiary, M.C.M. Environmental Technologies, Inc. The Company’s
innovative SteriMed technology simultaneously shreds and disinfects
solid and liquid regulated medical waste, reducing the volume by up to
90% and rendering it harmless for disposal as ordinary waste. The
SteriMed units are economical, compact, efficient and convenient, as
well as environmentally friendly. The MCM patented technology offers an
alternative to hauling and incinerating medical waste. Industry analysts
estimate the medical waste market to be approximately $3 billion in the
US and approximately $10 billion worldwide. More information on the
Company and MCM can be found at www.caprius.com
and www.mcmetech.com
Safe Harbor Statement
This press release may contain forward-looking statements that involve
risks and uncertainties. These statements refer to future plans,
objectives, expectations and intentions. These statements may be
identified by the use of words such as “anticipate,”“believe,”“intend,”“plan,”“expect”
and other similar expressions. The Company’s
actual results could differ materially from those discussed in, or
implied by, such forward-looking statements. You should also be aware of
risks and uncertainties that, in the Company’s
view, could cause actual results to differ materially including changes
related to regulatory and environmental approvals, manufacturing,
operations, capital needs, technological advances by competitors and
changes in health care reform, including reimbursement programs.
Certain information concerning economic trends and performance is based
upon or derived from information provided by third-party consultants and
other industry sources. While the Company believes that such information
is accurate and that the sources from which it was obtained are
reliable, it cannot guarantee the accuracy of such information, as it
has not independently verified the assumptions on which projections of
future trends and performance are based.
